Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
US11235030B2 · kind B2 · utility
0Cited by
116References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2019 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Oct 15, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions and methods for the treatment of tendinopathies, such as tenosynovitis, tendinosis or tendinitis, including Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis or “tennis elbow,” medial epicondylitis or “golfer's elbow,” plantar fasciitis, and rotator cuff tendinopathy, and in particular to methods for the treatment of tendinopathies by administering compositions comprising platelet-derived growth factor (PDGF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.